Seawolf surfaces with $100M, $1.2B Sanofi pact for redosable DNA medicines
Seawolf Therapeutics is unleashing with $100 million, while also spearing an up to $1.2 billion alliance with Sanofi, to develop…
Seawolf Therapeutics is unleashing with $100 million, while also spearing an up to $1.2 billion alliance with Sanofi, to develop…